Physiomics PLC Director Dealing (4939Z)
21 Mayo 2021 - 10:40AM
UK Regulatory
TIDMPYC
RNS Number : 4939Z
Physiomics PLC
21 May 2021
21 May 2021
Physiomics plc
("Physiomics") or ("the Company")
Director Dealing
The Company announces that Dr Jim Millen, Chief Executive
Officer of Physiomics, has transferred, for no consideration,
242,287 ordinary shares of 0.4p each in the Company ("Ordinary
Shares") from a brokerage account with James Brearley & Sons
Limited to an account with Interactive Investors. The Ordinary
Shares remain beneficially owned by Dr Millen.
Dr Millen's holding in the Company therefore remains 1,384,393
Ordinary Shares, representing approximately 1.42 per cent. of the
Company's issued share capital.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
Strand Hanson Ltd (NOMAD)
James Dance & James Bellman
+44 (0)20 7409 3494
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name James Millen
---------------------------------------------------------------- -----------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------------
a) Position/status Director, CEO
---------------------------------------------------------------- -----------------------------
b) Initial notification/ Amendment Initial notification
---------------------------------------------------------------- -----------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-----------------------------------------------------------------------------------------------
a) Name Physiomics plc
---------------------------------------------------------------- -----------------------------
b) LEI 213800A71DSZ6ABMTQ91
---------------------------------------------------------------- -----------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary share
Identification code
GB00BDR6W943
---------------------------------------------------------------- -----------------------------
b) Nature of the transaction Transfer of Ordinary Shares
---------------------------------------------------------------- -----------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 242,287
----------
---------------------------------------------------------------- -----------------------------
d) Aggregated information
* Aggregated volume 242,287
Nil
* Price
---------------------------------------------------------------- -----------------------------
e) Date of the transaction 21 May 2021
---------------------------------------------------------------- -----------------------------
f) Place of the transaction XLON, AIM
---------------------------------------------------------------- -----------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHABMATMTJTBTB
(END) Dow Jones Newswires
May 21, 2021 11:40 ET (15:40 GMT)
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024